Proteomics International Laboratories Ltd (PIQ.AX) Proteomics Presents at 17th Bioshares Biotech Summit
- 38
To view the presentation, please visit:
https://abnnewswire.net/lnk/7CF819PJ
About Proteomics International Laboratories Ltd:
Proteomics International Laboratories (ASX:PIQ) is a wholly owned subsidiary and trading name of PILL, a medical technology company at the forefront of predictive diagnostics and bioanalytical services. The Company specialises in the area of proteomics - the industrial scale study of the structure and function of proteins. Proteomics International's mission is to improve the quality of lives by the creation and application of innovative tools that enable the improved treatment of disease.
Source:
Proteomics International Laboratories Ltd
Contact:
Dr Richard Lipscombe Managing Director Proteomics International Laboratories Ltd T: +61 8 9389 1992 E: [email protected] Dirk van Dissel Investor Relations & Corporate Advisor Candour Advisory T: +61 408 326 367 E: [email protected] Kyle Moss Corporate Advisor Euroz Hartleys T: +61 8 9488 1400 E: [email protected]
ABN Newswire is a business newswire and press release distribution service for listed companies on stock exchanges globally. ABN Newswire distributes company announcements to the professional platforms, finance portals and syndicates important corporate news to a wide variety of news aggregators and financial news systems.
